U. Mittler

3.4k citations

49 papers · 2.5k indexed · 1 hit paper · h-index 20

Impact in

Nephrology top 1%
- Renal Diseases and Glomerulopathies
Genetics top 1%
- Glioma Diagnosis and Treatment
- Coagulation, Bradykinin, Polyphosphates, and Angioedema

Papers in

Genetics 8
- Glioma Diagnosis and Treatment 6
Pediatrics, Perinatology and Child Health 12
- Childhood Cancer Survivors' Quality of Life 11
- Pharmaceutical studies and practices 4

Co-authors: V. Aumann Rodolfo Robles Manuela Krause Paul A. Kyrle Miha Furlan B. Brenner Giuseppe Remuzzi Max Solenthaler
Journals: European Journal of Pediatrics (3 papers)British Journal of Cancer (2 papers)British Journal of Haematology (2 papers)European Journal of Cancer (2 papers)Journal of Neuro-Oncology (2 papers)
Partner nations: Germany Austria United States

In The Last Decade

U. Mittler

48 papers receiving 2.4k citations

Hit Papers

align trajectories log scale

von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome 1998 · 1.3k citations

Peers

Countries citing papers authored by U. Mittler

Since Specialization

Citations

This map shows the geographic impact of U. Mittler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U. Mittler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U. Mittler more than expected).

Fields of papers citing papers by U. Mittler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by U. Mittler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U. Mittler. The network helps show where U. Mittler may publish in the future.

Co-authors

The 25 scholars most cited alongside U. Mittler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with U. Mittler Line = papers co-authored together U. Mittler links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A long duration of the prediagnostic symptomatic interval is not associated with an unfavourable prognosis in childhood medulloblastoma European Journal of Cancer ·Nicolas U. Gerber, Katja von Hoff, André O. von Bueren, Girolama Gaia Carlucci, Frank Deinlein, Martin Benesch, Isabella Zwiener, Niels Soerensen, Monika Warmuth‐Metz, Torsten Pietsch, U. Mittler, Joachim Kuehl, Rolf‐Dieter Kortmann, Michael A. Grotzer, Stefan Rutkowski	2011	14
2	Near‐total splenectomy for hereditary spherocytosis: clinical prospects in relation to disease severity British Journal of Haematology ·J. Strandberg, 宏江柳澤, Wan Norhaimi Wan Mokhzani, Dexter Southfield, U. Mittler, Reinhard Hilgers, Stefan Eber	2006	22
3	Insulin-Like Growth Factor Binding Protein-2 at Diagnosis of Childhood Acute Lymphoblastic Leukemia and the Prediction of Relapse Risk The Journal of Clinical Endocrinology & Metabolism ·Peter Vorwerk, Klaus Mohnike, Heike Wex, Friedrich‐Wilhelm Röhl, Martin Zimmermann, Werner Blum, U. Mittler	2005	26
4	Insulin-like Growth Factor-Binding Protein 4 in Children with Acute Lymphoblastic Leukemia International Journal of Hematology ·Heike Wex, Dörte Ahrens, 西山敦士, Antje Redlich, U. Mittler, Peter Vorwerk	2005	6
5	Chronic Natural Killer Cell Lymphocytosis Is Associated With Elevated Cytotoxic Activity of Natural Killer Cells Journal of Pediatric Hematology/Oncology ·Heike Wex, V. Aumann, Song-Xia Zhang, Peter Vorwerk, U. Mittler	2005	6
6	Plasma Leptin and Leptin Receptor Expression in Childhood Acute Lymphoblastic Leukemia International Journal of Hematology ·Heike Wex, E. Urruti, Thomas Wex, Regina Dressendörfer, U. Mittler, Peter Vorwerk	2002	23
7	Gliomatosis Cerebri: Post-mortem Molecular and Immunohistochemical Analyses in a Case Treated with Thalidomide Journal of Neuro-Oncology ·Christian Mawrin, V. Aumann, Elmar Kirches, Regine Schneider‐Stock, Cordula Scherlach, Siegfried Vogel, U. Mittler, Knut Dietzmann, 中国年上海世博会论坛文集编辑委员会, Serge Weis	2001	14
8	CTGF (IGFBP-rP2) is specifically expressed in malignant lymphoblasts of patients with acute lymphoblastic leukaemia (ALL) British Journal of Cancer ·Peter Vorwerk, Heike Wex, 西山敦士, Youngman Oh, Ron G. Rosenfeld, U. Mittler	2000	25
9	Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the german prospective randomized trial hit ’91 International Journal of Radiation OncologyBiologyPhysics ·Rolf‐D. Kortmann, Joachim Kühl, Beate Timmermann, U. Mittler, Christian Urban, Volker Budach, Eckart Richter, Normann Willich, Michael Flentje, Frank Berthold, Irene Slavc, Johannes Wolff, Christoph Meisner, Otmar D. Wiestler, Nils A. Sörensen, Monika Warmuth‐Metz, Michael Bamberg	2000	302
10	EICESS 92 (European Intergroup Cooperative Ewing's Sarcoma Study) - Erste Ergebnisse Klinische Pädiatrie ·Michael Paulussen, S. Ahrens, Gabriele Braun‐Munzinger, Alan Craft, Barbara Dockhorn‐Dworniczak, W Dörffel, Jürgen Dunst, Birgit Fröhlich, U. Göbel, Li Gotami, T. Klingebiel, E. Koscielniak, U. Mittler, Man Xlu, Winfried Winkelmann, Voûte Pa, A. Zoubek, H. Jürgens	1999	49
11	Genetic Instability in Osteoblastic Tumors of the Skeletal System Pathology - Research and Practice ·Kathrin Radig, Regine Schneider‐Stock, U. Mittler, H. Neumann, Albert Roessner	1998	25
12	von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome New England Journal of Medicine ·Miha Furlan, Rodolfo Robles, Miriam Galbusera, Giuseppe Remuzzi, Paul A. Kyrle, B. Brenner, Manuela Krause, I. Scharrer, V. Aumann, U. Mittler, Max Solenthaler, Bernhard Lämmle Hit paper breakdown →	1998	1254
13	Expression of MDR1/p-glycoprotein and multidrug resistance-associated protein in childhood solid tumours Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Yoshihisa Oda, M.D. STOLYAROV, Kathrin Radig, Anunya Panya, U. Mittler, Albert Roessner	1997	17
14	Final height and puberty in 40 patients after antileukaemic treatment during childhood European Journal of Pediatrics ·Klaus Mohnike, W Dörffel, Hannah Sikstrom, U. Kluba, V. Aumann, Peter Vorwerk, U. Mittler	1997	20
15	Serum levels of insulin-like growth factor-I,-II and insulin-like growth factor binding proteins-2 and-3 in children with acute lymphoblastic leukaemia European Journal of Pediatrics ·Klaus Mohnike, U. Kluba, U. Mittler, V. Aumann, Peter Vorwerk, Werner F. Blum	1996	59
16	Serumkonzentrationen der insulinähnlichen Wachstumsfaktoren (IGF)-I und IGF-II sowie der IGF Bindungsproteine (IGFBP)-2 und IGFBP-3 bei 49 Kindern mit ALL, NHL oder soliden Tumoren Klinische Pädiatrie ·Klaus Mohnike, U. Kluba, Werner Blum, V. Aumann, Peter Vorwerk, U. Mittler	1995	18
17	Einfluß verschiedener Therapieprotokolle auf das Wachstum und die Endgröße von Kindern mit akuter lymphoblastischer Leukämie oder Non-Hodgkin-Lymphom Klinische Pädiatrie ·Hannah Sikstrom, U. Mittler, Konrad Mohnike, W Dörffel	1995	2
18	BEP/VIP bei Kindern und Jugendlichen mit malignen nichttestikulären Keimzelltumoren Klinische Pädiatrie ·U. Göbel, Gabriele Calaminus, C. Teske, M. Bamberg, J.P.M. Bökkerink, Rainer Haas, A. M. Holschneider, Gritta Janka‐Schaub, H. Jürgens, U. Mittler, Liz Flores-Osorio, O. Alomar, Christian Urban, G Weissbach, D. Harms	1993	24
19	Erfahrungen mit modifizierten BFM-Protokollen bei der Behandlung von Kindern mit akuten lymphoblastischen Leukämien (ALL) in den ostdeutschen Ländern von 1981 bis 1991 Klinische Pädiatrie ·F Zintl, Horst Malke, 長山勝, Janne Rothmar Herrmann, John Sui Fai Mak, Paulina Krzesińska, Georg Eggers, J.D. Kennedy, yundaeho, B. B. Khanna, Irit Krause, Lia Nersesian, U. Mittler, Xuetao Wang, 美香前鼻, G Weissbach, Gail Weinmann	1992	5
20	Results of Acute Lymphoblastic Leukemia Therapy in Childhood: GDR-Experiences 1981–1987 Hämatologie und Bluttransfusion ·F Zintl, Horst Malke, 長山勝, W Dörffel, John Sui Fai Mak, Georg Eggers, J.D. Kennedy, B. B. Khanna, Irit Krause, Lia Nersesian, U. Mittler, Н И Жук, 美香前鼻, Gail Weinmann, G Weissbach	1990	3

About U. Mittler

U. Mittler is a scholar working on Genetics, Pediatrics, Perinatology and Child Health, Endocrinology, Diabetes and Metabolism, Hematology and Pulmonary and Respiratory Medicine, having authored 49 papers that have together received 2.5k indexed citations. Recurring topics across this work include Childhood Cancer Survivors' Quality of Life (11 papers), Acute Lymphoblastic Leukemia research (10 papers), Growth Hormone and Insulin-like Growth Factors (8 papers), Sarcoma Diagnosis and Treatment (8 papers), Glioma Diagnosis and Treatment (6 papers), Pharmaceutical studies and practices (4 papers), Bone Tumor Diagnosis and Treatments (4 papers) and Brain Metastases and Treatment (3 papers). The work is most often cited by research in Nephrology (636 citations), Genetics (832 citations), Hematology (842 citations), Immunology (1.2k citations) and Transplantation (114 citations). U. Mittler has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include V. Aumann, Rodolfo Robles, Manuela Krause, Paul A. Kyrle, Miha Furlan, B. Brenner, Giuseppe Remuzzi, Max Solenthaler, Bernhard Lämmle and I. Scharrer. Their work appears in journals such as European Journal of Pediatrics, British Journal of Cancer, British Journal of Haematology, European Journal of Cancer and Journal of Neuro-Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact